Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons--43 U.S. Jurisdictions, July 31-October 1, 2022

Authors :: Payne, Amanda B.
Ray, Logan C.
Cole, Matthew M.
Canning, Michelle
Houck, Kennedy
Shah, Hazel J.
Farrar, Jennifer L.
Lewis, Nathaniel M.
Fothergill, Amy
White, Elizabeth B.
Feldstein, Leora R.
Roper, Lauren E.
Lee, Florence
Kriss, Jennifer L.
Sims, Emily
Spicknall, Ian H.
Nakazawa, Yoshinori
Gundlapalli, Adi V.
Shimabukuro, Tom
Cohen, Adam L.
Honein, Margaret A.
Mermin, Jonathan
Payne, Daniel C.
Source :: Morbidity and Mortality Weekly Report. December 9, 2022, Vol. 71 Issue 49, p1560, 5 p.
Publication Year :: 2022
Abstract: As of October 28, 2022, a total of 28,244 * monkeypox (mpox) cases have been reported in the United States during an outbreak that has disproportionately affected gay, bisexual, and [...]

Subjects :: United States. Food and Drug Administration
Jurisdiction
Drug approval
Vaccines
Health

Tools